Sclerostin antibody treatment enhances m
✍
Fredrik Agholme; Xiaodong Li; Hanna Isaksson; Hua Zhu Ke; Per Aspenberg
📂
Article
📅
2010
🏛
American Society for Bone and Mineral Research
🌐
English
⚖ 284 KB
## Abstract Sclerostin is the product of the __SOST__ gene. Loss‐of‐function mutations in the __SOST__ gene result in a high‐bone‐mass phenotype, demonstrating that sclerostin is a negative regulator of bone mass. Primarily expressed by osteocytes in bone, sclerostin is reported to bind the LRP5/6